Heterozygous Pathogenic and Likely Pathogenic Symptomatic HTRA1 Variant Carriers in Cerebral Small Vessel Disease

References

• Li T, Huang Y, Cai W, et al. Age-related cerebral small vessel disease and inflammaging. Cell Death Dis. 2020;11(10):932. doi:10.1038/s41419-020-03137-x
   PubMed Web of Science ®Google Scholar
• Pantoni L. Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges. Lancet Neurol. 2010;9(7):689–701. doi:10.1016/S1474-4422(10)70104-6
   PubMed Web of Science ®Google Scholar
• Haffner C, Malik R, Dichgans M. Genetic factors in cerebral small vessel disease and their impact on stroke and dementia. J Cereb Blood Flow Metab. 2016;36(1):158–171. doi:10.1038/jcbfm.2015.71
   PubMed Web of Science ®Google Scholar
• Joutel A, Corpechot C, Ducros A, et al. Notch3 mutations in CADASIL, a hereditary adult-onset condition causing stroke and dementia. Nature. 1996;383(6602):707–710. doi:10.1038/383707a0
   PubMed Web of Science ®Google Scholar
• Hara K, Shiga A, Fukutake T, et al. Association of HTRA1 mutations and familial ischemic cerebral small-vessel disease. N Engl J Med. 2009;360(17):1729–1739.
   PubMed Web of Science ®Google Scholar
• Verdura E, Herve D, Scharrer E, et al. Heterozygous HTRA1 mutations are associated with autosomal dominant cerebral small vessel disease. Brain. 2015;138(Pt 8):2347–2358. doi:10.1093/brain/awv155
   PubMedGoogle Scholar
• Richards A, van den Maagdenberg AM, Jen JC, et al. C-terminal truncations in human 3’-5’ DNA exonuclease TREX1 cause autosomal dominant retinal vasculopathy with cerebral leukodystrophy. Nat Genet. 2007;39(9):1068–1070. doi:10.1038/ng2082
   PubMed Web of Science ®Google Scholar
• Gould DB, Phalan FC, Breedveld GJ, et al. Mutations in Col4a1 cause perinatal cerebral hemorrhage and porencephaly. Science. 2005;308(5725):1167–1171. doi:10.1126/science.1109418
   PubMed Web of Science ®Google Scholar
• Yoneda Y, Haginoya K, Arai H, et al. De novo and inherited mutations in COL4A2, encoding the type IV collagen α2 chain cause porencephaly. Am J Hum Genet. 2012;90(1):86–90. doi:10.1016/j.ajhg.2011.11.016
   PubMed Web of Science ®Google Scholar
• Bugiani M, Kevelam SH, Bakels HS, et al. Cathepsin A-related arteriopathy with strokes and leukoencephalopathy (CARASAL). Neurology. 2016;87(17):1777–1786. doi:10.1212/WNL.0000000000003251
   PubMed Web of Science ®Google Scholar
• Bernstein HS, Bishop DF, Astrin KH, et al. Fabry disease: six gene rearrangements and an exonic point mutation in the alpha-galactosidase gene. J Clin Invest. 1989;83(4):1390–1399. doi:10.1172/JCI114027
   PubMed Web of Science ®Google Scholar
• Mizuno T, Mizuta I, Watanabe-Hosomi A, Mukai M, Koizumi T. Clinical and genetic aspects of CADASIL. Front Aging Neurosci. 2020;12:91. doi:10.3389/fnagi.2020.00091
   PubMed Web of Science ®Google Scholar
• Uemura M, Nozaki H, Onodera O. Cerebral Autosomal Recessive Arteriopathy with Subcortical Infarcts and Leukoencephalopathy (CARASIL). Brain Nerve. 2017;69(1):25–33. doi:10.11477/mf.1416200631
   PubMedGoogle Scholar
• Richards S, Aziz N, Bale S, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17(5):405–424. doi:10.1038/gim.2015.30
   PubMed Web of Science ®Google Scholar
• De Luca A, De Falco M, Severino A, et al. Distribution of the serine protease HtrA1 in normal human tissues. J Histochem Cytochem. 2003;51(10):1279–1284. doi:10.1177/002215540305101004
   PubMed Web of Science ®Google Scholar
• Eigenbrot C, Ultsch M, Lipari MT, et al. Structural and functional analysis of HtrA1 and its subdomains. Structure. 2012;20(6):1040–1050. doi:10.1016/j.str.2012.03.021
   PubMed Web of Science ®Google Scholar
• Uemura M, Nozaki H, Kato T, et al. HTRA1-related cerebral small vessel disease: a review of the literature. Front Neurol. 2020;11:545. doi:10.3389/fneur.2020.00545
   PubMed Web of Science ®Google Scholar
• Liu J, Zhu Y, Zhou L, et al. HTRA1-related autosomal dominant cerebral small vessel disease. Chin Med J. 2020;134(2):178–184. doi:10.1097/CM9.0000000000001176
   PubMed Web of Science ®Google Scholar
• Yu Z, Cao S, Wu A, et al. Genetically confirmed CARASIL: case report with novel HTRA1 mutation and literature review. World Neurosurg. 2020;143:121–128. doi:10.1016/j.wneu.2020.05.128
   PubMed Web of Science ®Google Scholar
• Nozaki H, Kato T, Nihonmatsu M, et al. Distinct molecular mechanisms of HTRA1 mutants in manifesting heterozygotes with CARASIL. Neurology. 2016;86(21):1964–1974. doi:10.1212/WNL.0000000000002694
   PubMed Web of Science ®Google Scholar
• Bougea A. Do heterozygous HTRA1 mutations carriers form a distinct clinical entity? CNS Neurosci Ther. 2018;24(12):1299–1300. doi:10.1111/cns.13047
   PubMed Web of Science ®Google Scholar
• Xie F, Zhang LS. A Chinese CARASIL patient caused by novel compound heterozygous mutations in HTRA1. J Stroke Cerebrovasc Dis. 2018;27(10):2840–2842. doi:10.1016/j.jstrokecerebrovasdis.2018.06.017
   PubMed Web of Science ®Google Scholar
• Ragno M, Pianese L, Caulo M, et al. Cutaneous sensory and autonomic small fiber neuropathy in HTRA1-related cerebral small vessel disease. J Neuropathol Exp Neurol. 2020;80:713.
   Web of Science ®Google Scholar
• Favaretto S, Margoni M, Salviati L, Pianese L, Manara R, Baracchini C. A new Italian family with HTRA1 mutation associated with autosomal-dominant variant of CARASIL: are we pointing towards a disease spectrum? J Neurol Sci. 2019;396:108–111. doi:10.1016/j.jns.2018.11.008
   PubMed Web of Science ®Google Scholar
• Mancuso M, Arnold M, Bersano A, et al. Monogenic cerebral small-vessel diseases: diagnosis and therapy. Consensus recommendations of the European Academy of Neurology. Eur J Neurol. 2020;27(6):909–927. doi:10.1111/ene.14183
   PubMed Web of Science ®Google Scholar
• Zhang H, Qin X, Shi Y, et al. Genotype-phenotype correlations of heterozygous HTRA1-related cerebral small vessel disease: case report and systematic review. Neurogenetics. 2021;22(3):187–194. doi:10.1007/s10048-021-00646-5
   PubMed Web of Science ®Google Scholar
• Muthusamy K, Ferrer A, Klee EW, Wierenga KJ, Gavrilova RH. Clinicoradiographic and genetic features of cerebral small vessel disease indicate variability in mode of inheritance for monoallelic HTRA1 variants. Mol Genet Genomic Med. 2021;9(10):e1799. doi:10.1002/mgg3.1799
   PubMed Web of Science ®Google Scholar
• Malik R, Beaufort N, Frerich S, et al. Whole-exome sequencing reveals a role of HTRA1 and EGFL8 in brain white matter hyperintensities. Brain. 2021;144(9):2670–2682. doi:10.1093/brain/awab253
   PubMedGoogle Scholar
• Shen L, Thompson PM. Brain imaging genomics: integrated analysis and machine learning. Proc IEEE Inst Electr Electron Eng. 2020;108(1):125–162. doi:10.1109/JPROC.2019.2947272
   PubMed Web of Science ®Google Scholar
• Lee YC, Chung CP, Chao NC, et al. Characterization of heterozygous HTRA1 mutations in Taiwanese patients with cerebral small vessel disease. Stroke. 2018;49(7):1593–1601. doi:10.1161/STROKEAHA.118.021283
   PubMed Web of Science ®Google Scholar
• Thaler FS, Catak C, Einhäupl M, et al. Cerebral small vessel disease caused by a novel heterozygous mutation in HTRA1. J Neurol Sci. 2018;388:19–21. doi:10.1016/j.jns.2018.02.043
   PubMed Web of Science ®Google Scholar
• Zhang WY, Xie F, Lu PL. Two novel heterozygous HTRA1 mutations in two pedigrees with cerebral small vessel disease families. Neurol Sci. 2018;39(3):497–501. doi:10.1007/s10072-017-3231-z
   PubMed Web of Science ®Google Scholar
• Zhou H, Jiao B, Ouyang Z, Wu Q, Shen L, Fang L. Report of two pedigrees with heterozygous HTRA1 variants-related cerebral small vessel disease and literature review. Mol Genet Genomic Med. 2022;10(10):e2032. doi:10.1002/mgg3.2032
   PubMed Web of Science ®Google Scholar
• Ohta K, Ozawa T, Fujinaka H, Goto K, Nakajima T. Cerebral small vessel disease related to a heterozygous nonsense mutation in HTRA1. Intern Med. 2020;59(10):1309–1313. doi:10.2169/internalmedicine.4041-19
   PubMed Web of Science ®Google Scholar
• Tateoka T, Onda H, Hirota K, et al. Unusual case of cerebral small vessel disease with a heterozygous nonsense mutation in HTRA1. J Neurol Sci. 2016;362:144–146. doi:10.1016/j.jns.2016.01.037
   PubMed Web of Science ®Google Scholar
• Chen MJ, Zhang Y, Luo WJ, et al. Identified novel heterozygous HTRA1 pathogenic variants in Chinese patients with HTRA1-associated dominant cerebral small vessel disease. Front Genet. 2022;13:909131. doi:10.3389/fgene.2022.909131
   PubMed Web of Science ®Google Scholar
• Zhang C, Zheng H, Li X, et al. Novel mutations in HTRA1-related cerebral small vessel disease and comparison with CADASIL. Ann Clin Transl Neurol. 2022;9(10):1586–1595. doi:10.1056/NEJMoa0801560
   PubMed Web of Science ®Google Scholar
• Coste T, Hervé D, Neau J, et al. Heterozygous HTRA1 nonsense or frameshift mutations are pathogenic. Brain. 2021;144(9):2616–2624. doi:10.1093/brain/awab271
   PubMedGoogle Scholar
• Fasano A, Formichi P, Taglia I, et al. HTRA1 expression profile and activity on TGF-β signaling in HTRA1 mutation carriers. J Cell Physiol. 2020;235(10):7120–7127. doi:10.1002/jcp.29609
   PubMed Web of Science ®Google Scholar
• Truebestein L, Tennstaedt A, Mönig T, et al. Substrate-induced remodeling of the active site regulates human HTRA1 activity. Nat Struct Mol Biol. 2011;18(3):386–388.
   PubMed Web of Science ®Google Scholar
• Uemura M, Nozaki H, Koyama A, et al. HTRA1 mutations identified in symptomatic carriers have the property of interfering the trimer-dependent activation cascade. Front Neurol. 2019;10:693. doi:10.3389/fneur.2019.00693
   PubMed Web of Science ®Google Scholar
• Zhuo ZL, Cong L, Zhang J, Zhao XT. A novel heterozygous HTRA1 mutation is associated with autosomal dominant hereditary cerebral small vessel disease. Mol Genet Genomic Med. 2020;8(6):e1111. doi:10.1002/mgg3.1111
   PubMed Web of Science ®Google Scholar
• Jin SF, Wang YX, Xu N, et al. High temperature requirement factor A1 (HTRA1) regulates the activation of latent TGF-β1 in keloid fibroblasts. Cell Mol Biol. 2018;64(1):107–110. doi:10.14715/cmb/2018.64.2.19
   PubMed Web of Science ®Google Scholar
• Kato T, Manabe RI, Igarashi H, et al. Candesartan prevents arteriopathy progression in cerebral autosomal recessive arteriopathy with subcortical infarcts and leukoencephalopathy model. J Clin Invest. 2021;131:22. doi:10.1172/JCI140555
   Web of Science ®Google Scholar
• Ruiz-Ortega M, Rodriguez-Vita J, Sanchez-Lopez E, et al. TGF-β signaling in vascular fibrosis. Cardiovasc Res. 2007;74:196–206. doi:10.1016/j.cardiores.2007.02.008
   PubMed Web of Science ®Google Scholar
• Onodera O. TGF-β family signaling contributes to human cerebral small vessel disease. Rinsho shinkeigaku. 2011;51(11):943–944. doi:10.5692/clinicalneurol.51.943
   PubMedGoogle Scholar
• Plikus MV, Mayer JA, Damon D, et al. Cyclic dermal BMP signalling regulates stem cell activation during hair regeneration. Nature. 2008;451(7176):340. doi:10.1038/nature06457
   PubMed Web of Science ®Google Scholar
• Ghorbani Z, Rafiee P, Haghighi S, Jahromi SR, Togha M. The effects of vitamin D3 supplementation on TGF-β and IL-17 serum levels in migraineurs: post hoc analysis of a randomized clinical trial. J Pharm Health Care Sci. 2021;7(1):9. doi:10.1186/s40780-021-00192-0
   PubMed Web of Science ®Google Scholar
• Joshi N, Minz RW, Anand S, Parmar NV, Kanwar AJ. Vitamin D deficiency and lower TGF-β/IL-17 ratio in a North Indian cohort of pemphigus vulgaris. BMC Res Notes. 2014;7(1):536. doi:10.1186/1756-0500-7-536
   PubMedGoogle Scholar
• Bar-Klein G, Cacheaux LP, Kamintsky L, et al. Losartan prevents acquired epilepsy via TGF-β signaling suppression. Ann Neurol. 2014;75(6):864–875. doi:10.1002/ana.24147
   PubMed Web of Science ®Google Scholar
• Ito J, Nozaki H, Toyoshima Y, et al. Histopathologic features of an autopsied patient with cerebral small vessel disease and a heterozygous HTRA1 mutation. Neuropathology. 2018;38(4):428–432. doi:10.1111/neup.12473
   Web of Science ®Google Scholar
• Caplan L, Gomes J. Binswanger disease--an update. J Neurol Sci. 2010;299:9–10. doi:10.1016/j.jns.2010.08.041
   PubMed Web of Science ®Google Scholar
• Bougea A, Velonakis G, Spantideas N, et al. The first Greek case of heterozygous cerebral autosomal recessive arteriopathy with subcortical infarcts and leukoencephalopathy: an atypical clinico-radiological presentation. Neuroradiol J. 2017;30(6):583–585. doi:10.1177/1971400917700168
   PubMedGoogle Scholar
• Cao H, Liu J, Tian W, et al. A novel heterozygous HTRA1 mutation in an Asian family with CADASIL-like disease. J Clin Lab Anal. 2022;36(2):e24174. doi:10.1002/jcla.24174
   PubMed Web of Science ®Google Scholar
• Di Donato I, Bianchi S, Gallus GN, et al. Heterozygous mutations of HTRA1 gene in patients with familial cerebral small vessel disease. CNS Neurosci Ther. 2017;23(9):759–765. doi:10.1111/cns.12722
   PubMed Web of Science ®Google Scholar
• Shang T, Pinho M, Ray D, Khera A. Two unique mutations in HTRA1-related cerebral small vessel disease in North America And Africa and literature review. J Stroke Cerebrovasc Dis. 2021;30(11):106029. doi:10.1016/j.jstrokecerebrovasdis.2021.106029
   PubMed Web of Science ®Google Scholar
• Wu X, Li C, Mao J, Li L, Liu Y, Hou Y. Heterozygous HTRA1 missense mutation in CADASIL-like family disease. Braz J Med Biol Res. 2018;51(5):e6632. doi:10.1590/1414-431x20176632
   PubMed Web of Science ®Google Scholar
• Mahale R, Agarwal A, Gautam J, et al. HTRA1 autosomal dominant cerebral small vessel disease in gene mutation. Ann Indian Acad Neurol. 2021;24(2):297–299. doi:10.4103/aian.AIAN_381_20
   PubMed Web of Science ®Google Scholar